FDA notifications. FDA changes information for stavudine label.
D000140:Acidosis, Lactic / Q000139:chemically induced; D004348:Drug Labeling; D006801:Humans; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects*; D018119:Stavudine / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration
D018894:Reverse Transcriptase Inhibitors; D018119:Stavudine